Dermatomyositis and Polymyositis Registry
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Skin and Soft Tissue Infections, Nephrology |
| Therapuetic Areas: | Dermatology / Plastic Surgery, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - 85 |
| Updated: | 4/21/2016 |
| Start Date: | April 2013 |
Acthar Dermatomyositis and Polymyositis Treatment
By creating a registry, physicians will have the opportunity to understand the clinical
outcomes of Myositis patients treated with Acthar. Despite the availability of clinical
exams, muscle biopsies, and other testing, it is surmised that there may be a more important
classification of myositis that physicians are not diagnosing which could possibly lead to
improper treatment due to inaccurate diagnosis. There may be several types of immune and
inflammatory myositis (IIM) that do not fit well into the typical sub classifications of
myositis.
outcomes of Myositis patients treated with Acthar. Despite the availability of clinical
exams, muscle biopsies, and other testing, it is surmised that there may be a more important
classification of myositis that physicians are not diagnosing which could possibly lead to
improper treatment due to inaccurate diagnosis. There may be several types of immune and
inflammatory myositis (IIM) that do not fit well into the typical sub classifications of
myositis.
Retrospective and prospective data will be collected from physicians who have prescribed
Acthar to myositis patients to determine what specific characteristics each patient has
based on biopsy analysis, laboratory results, and clinical exams. Through biopsy analysis,
subcategories of IIM will be determined and could illustrate which of these IIMs may be more
responsive to Acthar therapy.
Acthar to myositis patients to determine what specific characteristics each patient has
based on biopsy analysis, laboratory results, and clinical exams. Through biopsy analysis,
subcategories of IIM will be determined and could illustrate which of these IIMs may be more
responsive to Acthar therapy.
Inclusion Criteria:
1. Age 18-85
2. Male or Female
3. Clinical or pathologic diagnosis of polymyositis or dermatomyositis
4. Capable of providing informed consent and complying with treatment regimen
Exclusion Criteria:
1. History of scleroderma, osteoporosis, systemic fungal infections, ocular herpes
simplex
2. Recent surgery, history of or the presence of a peptic ulcer, congestive heart
failure, uncontrolled hypertension, or sensitivity to proteins of porcine origin
3. Any other co-morbid condition which would make completion of the trial unlikely
4. If female, pregnant or breast-feeding; or, if of childbearing age, an unwillingness
to use appropriate birth control
We found this trial at
5
sites
University of Vermont The University of Vermont combines faculty-student relationships most commonly found in a...
Click here to add this to my saved trials
New York Methodist Hospital A voluntary, acute-care teaching hospital, New York Methodist Hospital's mission is...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials